免疫介导疾病与癌症风险的相关性
这项前瞻性队列研究基于英国生物银行478 753名37至73岁参与者,随访至2019年2月28日,评估48种免疫介导疾病与总癌及各类癌症风险的关系。免疫介导疾病与总癌风险升高相关(多变量HR 1.08,95%CI 1.04-1.12),器官特异性免疫介导疾病与局部癌症的关联强于远处癌症。
要点
- 免疫介导疾病患者总癌风险升高(多变量HR 1.08,95%CI 1.04-1.12)。
- 哮喘、乳糜泻、特发性血小板减少性紫癜、原发性胆汁性胆管炎和自身免疫性肝炎与局部癌症风险升高相关(异质性P<.002)。
- 9种免疫介导疾病与受累器官癌症风险升高相关,13种与邻近或远处器官癌症风险升高相关。
核心结论
- 免疫介导疾病与总癌风险升高相关;器官特异性免疫介导疾病与局部癌症的关联强于远处癌症;各免疫介导疾病的关联主要呈器官特异性,但也见于邻近器官、远处器官或不同系统的某些癌症;研究结果支持局部和全身免疫调节在癌症发生中的作用。
研究设计与样本
- 前瞻性队列研究,使用英国生物银行队列数据,纳入2006年1月1日至2010年12月31日在英国22个评估中心招募的37至73岁成人,随访至2019年2月28日。
- 共纳入478 753名参与者(平均[SD]年龄56.4[8.1]岁;54%为女性)。
- 采用时变Cox比例风险回归计算多变量风险比(HR)及95%CI,调整多种潜在混杂因素;采用对比检验法评估器官特异性免疫介导疾病与局部及远处癌症关联的异质性。
主要发现
- 随访4 600 460人年期间,61 496例免疫介导疾病患者中记录2834例癌症,417 257例无免疫介导疾病者中记录26 817例癌症(多变量HR 1.08;95%CI 1.04-1.12)。
- 5种器官特异性免疫介导疾病与局部癌症风险升高显著相关而与远处癌症无关:哮喘(HR 1.34;95%CI 1.14-1.56)、乳糜泻(HR 6.89;95%CI 2.18-21.75)、特发性血小板减少性紫癜(HR 6.94;95%CI 3.94-12.25)、原发性胆汁性胆管炎(HR 42.12;95%CI 20.76-85.44)、自身免疫性肝炎(HR 21.26;95%CI 6.79-66.61)(异质性P<.002)。
- 9种免疫介导疾病与受累器官癌症风险升高相关,例如哮喘与肺癌(HR 1.34;95%CI 1.14-1.57;P<.001)、乳糜泻与小肠癌(HR 6.89;95%CI 2.18-21.75;P=.001)。
- 13种免疫介导疾病与邻近器官癌症风险升高相关(例如克罗恩病与肝癌:HR 4.01;95%CI 1.65-9.72;P=.002)或远处器官癌症风险升高相关(例如自身免疫性肝炎与舌癌:HR 27.75;95%CI 3.82-199.91;P=.001)或不同系统癌症风险升高相关(例如特发性血小板减少性紫癜与肝癌:HR 11.96;95%CI 3.82-37.42;P<.001)。
关键数值与推荐
- 原文未报告。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Immune regulation is important for carcinogenesis; however, the cancer risk profiles associated with immune-mediated diseases need further characterization. OBJECTIVE: To assess the prospective association of 48 immune-mediated diseases with the risk of total and individual cancers and the prospective association of organ-specific immune-mediated diseases with the risk of local and extralocal cancers. DESIGN, SETTING, AND PARTICIPANTS: This prospective cohort study used data from the UK Biobank cohort study on adults aged 37 to 73 years who were recruited at 22 assessment centers throughout the UK between January 1, 2006, and December 31, 2010, with follow-up through February 28, 2019. EXPOSURES: Immune-mediated diseases. MAIN OUTCOMES AND MEASURES: The association of immune-mediated diseases with risk of cancer was assessed with multivariable hazard ratios (HRs) and 95% CIs after adjusting for various potential confounders using time-varying Cox proportional hazards regression. Heterogeneity in the associations of organ-specific immune-mediated diseases with local and extralocal cancers was assessed using the contrast test method. RESULTS: A total of 478 753 participants (mean [SD] age, 56.4 [8.1] years; 54% female) were included in the study. During 4 600 460 person-years of follow-up, a total of 2834 cases of cancer were documented in 61 496 patients with immune-mediated diseases and 26 817 cases of cancer in 417 257 patients without any immune-mediated diseases (multivariable HR, 1.08; 95% CI, 1.04-1.12). Five of the organ-specific immune-mediated diseases were significantly associated with higher risk of local but not extralocal cancers: asthma (HR, 1.34; 95% CI, 1.14-1.56), celiac disease (HR, 6.89; 95% CI, 2.18-21.75), idiopathic thrombocytopenic purpura (HR, 6.94; 95% CI, 3.94-12.25), primary biliary cholangitis (HR, 42.12; 95% CI, 20.76-85.44), and autoimmune hepatitis (HR, 21.26; 95% CI, 6.79-66.61) (P < .002 for heterogeneity). Nine immune-mediated diseases were associated with an increased risk of cancers in the involved organs (eg, asthma with lung cancer [HR, 1.34; 95% CI, 1.14-1.57; P < .001] and celiac disease with small intestine cancer [HR, 6.89; 95% CI, 2.18-21.75; P = .001]); 13 immune-mediated diseases were associated with an increased risk of cancer in the near organs (eg, Crohn disease with liver cancer: [HR, 4.01; 95% CI, 1.65-9.72; P = .002]) or distant organs (eg, autoimmune hepatitis with tongue cancer [HR, 27.75; 95% CI, 3.82-199.91; P = .001]) or in different systems (eg, idiopathic thrombocytopenic purpura with liver cancer [HR, 11.96; 95% CI, 3.82-37.42; P < .001]). CONCLUSIONS AND RELEVANCE: In this cohort study, immune-mediated diseases were associated with an increased risk of total cancer. Organ-specific immune-mediated diseases had stronger associations with risk of local cancers than extralocal cancers. The associations for individual immune-mediated diseases were largely organ specific but were also observed for some cancers in the near and distant organs or different systems. Our findings support the role of local and systemic immunoregulation in cancer development.
引用
- He MM, Lo CH, Wang K, et al. Immune-Mediated Diseases Associated With Cancer Risks. JAMA Oncol. 2022. PMID: 34854871. doi:10.1001/jamaoncol.2021.5680
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。